Qing Tang poisoned stasis combined hydroxyurea treatment of chronic myelogenous leukemia.doc

 PAGE \* MERGEFORMAT 4 Qing Tang poisoned stasis combined hydroxyurea treatment of chronic myelogenous leukemia Author: Zhou Yuhong Shen Yiping Han Junli [Keywords:] Qing Tang hydroxyurea poisoning Stasis chronic myelogenous leukemia Chronic myeloid leukemia (chronic myelocytic leukemia, CML) is a hematopoietic stem cell clone proliferative disease, bone marrow granulocyte hyperplasia, peripheral leukocytosis and spleen enlargement as the main feature. October 1996 ~ October 2004 our department treated 42 patients with good results in patients with CML are reported below. A clinical data CML patients, 72 cases were randomly divided into two groups, treatment group 42 cases, male 26 cases, female 16 cases, aged 19 to 74 years old, duration 2 to 36 months; peripheral blood: white blood cell (WBC) an average of 31 * 109 / L ; Bone marrow: The original cells, an average of 6%. The control group of 30 cases, male 18 cases, 12 females, aged from 23 to 73 years, duration 1 to 36 months; peripheral blood: WBC average 32 * 109 / L; bone marrow: The original cells, an average of 5%. Diagnosis are in line with ‘blood disease diagnosis and efficacy of standard’ in the relevant standards [1]. Patients were newly diagnosed by clinical symptoms, blood, bone marrow and Ph chromosome were positive and confirmed. Clinical manifestations of Abdominal Distension, Xiexia have blocks, soft but not kin, fixed embedded mamillata moss thin, pulse string, TCM is a cult poison intrusion, Qi stagnation blood stasis Tanning. Two groups of gender, age, hemogram, bone marrow, as such difference was not statistically significant (Pamp;gt; 0.05), comparable. Two treatment Control group was given hydroxyurea 1 day 1 ~ 3g, sub 1 ~ 3 times orally, the specific dosage according to the number of circumstances in patients with white blood cells, white blood cell count medication regularly during the investigation. The treatment group in the control group on the basis of the treatment plus clo